Clinical Research Directory
Browse clinical research sites, groups, and studies.
Increasing Access to Definitive Treatment for Prostate Cancer
Sponsor: Brigham and Women's Hospital
Summary
Investigators will address the overarching challenge of advancing health equity and reducing disparities in prostate cancer by informing efforts to reduce travel burden in prostate cancer (PCa) treatment access among Black men.
Official title: Increasing Access to Definitive Treatment for Prostate Cancer by Removing Transportation Barriers for UnderservedPatients: A Multilevel Feasibility Study
Key Details
Gender
MALE
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2023-09
Completion Date
2026-06
Last Updated
2023-09-14
Healthy Volunteers
No
Conditions
Interventions
Ride Share
The Investigators' proposed study addresses the Prostate Cancer Research Program overarching challenge of Advancing Health Equity and Reducing Disparities in PCa by examining and addressing travel burden to PCa treatment centers. Investigators will focus on Black men (including those of Caribbean descent), a high-risk population experiencing poorer health outcomes for unjust and preventable reasons. This research will inform efforts to reduce travel burden in the healthcare acquisition process and improve the timeliness of treatment in Black men with PCa in Massachusetts and other states. This project will improve the quality of life and enhance outcomes and overall health and wellness for this group. Investigators will use findings from this pilot study to obtain future funding for a multicenter randomized clinical trial that will estimate the effect of equity - oriented programs that remove transportation barriers to treatment and reduce Black-White disparities in PCa outcomes
Locations (1)
Brigham and Women's Hospital
Boston, Massachusetts, United States